MacroGenics | MGNX - Trade Debtors


MacroGenics reported $10.42M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Amgen USD 10.23B 1.09B Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Daiichi Sankyo JPY 676.92B 19.03B Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Genmab DKK 1.22B 192M Jun/2026
Geron USD 44.1M 4.87M Mar/2026
Gilead Sciences USD 5.06B 314M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
MacroGenics USD 10.42M 2.95M Mar/2026
Merck USD 12.21B 435M Mar/2026
Pfizer USD 16.19B 19M Jun/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Xencor USD 42.23M 30.23M Jun/2026